Discover key takeaways from Viking Therapeutics' Q1 2025 earnings call, including Phase 3 trial updates, financial performance, and obesity ...

Fox News host Greg Gutfeld went beyond the pale late Friday night with a crude joke about Katy Perry following her flight into space. “To prepare for her trip on the Blue Origin rocket ...

ANAHEIM, CA - APRIL 7: Head coach of the Anaheim Ducks, Greg Cronin, on the bench prior to the start of the game against the Edmonton Oilers on April 7, 2025 at Honda Center in Anaheim, California.

Viking Therapeutics, Inc. (VKTX) ended the recent trading session at $23.94, demonstrating a +1.44% swing from the preceding day's closing price. The stock outperformed the S&P 500, which ...

Shares of Viking Therapeutics (VKTX) are moving lower in pre-market trading after Eli Lilly (LLY) announced topline Phase 3 results from ACHIEVE-1, evaluating the safety and efficacy of ...

On Thursday, Truist Securities reaffirmed its Buy rating and $120.00 price target for Viking Therapeutics (NASDAQ:VKTX) stock. The ...

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is preparing for the possible FDA approval of its weight loss drug candidate ...

No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ: VKTX), the turbulence has been extremely challenging thus far.

Also Read: Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst Pfizer is one of several drugmakers working to develop an alternative to ...

Viking Therapeutics (NASDAQ: VKTX) is a healthcare company that possesses a lot of growth potential. And last year, its shares rose by 116%, as investors were bullish on its prospects. This year ...